Literature DB >> 26941093

Consumption of medicinal plants by patients with heart diseases at a pharmacist-managed anticoagulation clinic in Brazil.

Paula Mendonça Leite1, Rachel Oliveira Castilho1, Antonio Luiz Pinho Ribeiro1, Maria Auxiliadora Parreiras Martins2.   

Abstract

BACKGROUND: Medicinal plants (MP) have been used for many years with the purpose of feeding and curing. Several MP may interfere in drug response and are not always considered as potential drug-interactors in clinical practice.
OBJECTIVE: To investigate the consumption of MP by outpatients during a one-year follow-up.
METHOD: Patients with cardiopathy diagnosis and indication(s) for long-term use of warfarin were recruited at a pharmacist-managed anticoagulation clinic of a Brazilian public hospital. This research employed a descriptive method. The consumption of MP was examined regarding the type, frequency and forms of use.
RESULTS: A total of 280 patients were studied. Most patients were female (54.6 %) with an average age of 56.8 ± 13.1 years. The consumption of MP was reported by 46 (16.4 %) patients, totalizing 59 occurrences. Lemon, lemon balm and plantain were the most common MP. The main pharmacological uses involved the digestive, urinary, and respiratory tracts. Tea was the predominant form of consumption (87 %). Twelve (33.3 %) plants presented potential herb-warfarin interactions according to the literature.
CONCLUSION: We described the consumption of MP among outpatients characterized by their complex disease status, propensity for adverse events, and socioeconomic limitations. These results may guide pharmacist interventions and procedures to prevent clinical complications.

Entities:  

Keywords:  Anticoagulants; Heart diseases; Medicinal plants; Warfarin

Mesh:

Substances:

Year:  2016        PMID: 26941093     DOI: 10.1007/s11096-016-0270-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  9 in total

1.  The prevalence of herbs use in conjunction with conventional medicines in Jamaica.

Authors:  Rupika Delgoda; Novie Younger; Claudia Barrett; Jennifer Braithwaite; Denise Davis
Journal:  Complement Ther Med       Date:  2010-02-07       Impact factor: 2.446

Review 2.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

Review 3.  Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration.

Authors:  C Ulbricht; W Chao; D Costa; E Rusie-Seamon; W Weissner; J Woods
Journal:  Curr Drug Metab       Date:  2008-12       Impact factor: 3.731

Review 4.  Drug discovery and natural products: end of an era or an endless frontier?

Authors:  Jesse W-H Li; John C Vederas
Journal:  Science       Date:  2009-07-10       Impact factor: 47.728

5.  Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources.

Authors:  Maria A P Martins; Paula P S Carlos; Daniel D Ribeiro; Vandack A Nobre; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro
Journal:  Eur J Clin Pharmacol       Date:  2011-06-24       Impact factor: 2.953

Review 6.  Use of herbal products and potential interactions in patients with cardiovascular diseases.

Authors:  Ara Tachjian; Viqar Maria; Arshad Jahangir
Journal:  J Am Coll Cardiol       Date:  2010-02-09       Impact factor: 24.094

7.  Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.

Authors:  William L Baker; Deborah A Cios; Stephen D Sander; Craig I Coleman
Journal:  J Manag Care Pharm       Date:  2009-04

8.  Evaluation of extraction method on the chemical composition in Apeiba tibourbou Aubl's extracts.

Authors:  Frederico Severino Martins; Edemilson Cardoso da Conceição
Journal:  Pharmacogn Mag       Date:  2015 Apr-Jun       Impact factor: 1.085

Review 9.  Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions.

Authors:  Andre L D A Mazzari; Jose M Prieto
Journal:  Front Pharmacol       Date:  2014-07-09       Impact factor: 5.810

  9 in total
  2 in total

1.  Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin.

Authors:  Marcus Fernando S Praxedes; Maria Auxiliadora P Martins; Aline O M Mourão; Karina B Gomes; Edna A Reis; Renan P Souza; Emílio Itamar F Campos; Daniel D Ribeiro; Manoel Otávio C Rocha
Journal:  Eur J Clin Pharmacol       Date:  2019-11-12       Impact factor: 2.953

Review 2.  Melissa officinalis L. as a Nutritional Strategy for Cardioprotection.

Authors:  Nevena Draginic; Vladimir Jakovljevic; Marijana Andjic; Jovana Jeremic; Ivan Srejovic; Marina Rankovic; Marina Tomovic; Tamara Nikolic Turnic; Andrey Svistunov; Sergey Bolevich; Isidora Milosavljevic
Journal:  Front Physiol       Date:  2021-04-22       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.